This is a StreetInsider.com Premium Only Page

CymaBay Therapeutics (CBAY) – Trading Halts

Feb 12, 2024 08:34 AM CymaBay Therapeutics (CBAY) to Resume Trading at 9 a.m.

Feb 12, 2024 08:32 AM Gilead Sciences (GILD) to Acquire CymaBay Therapeutics (CBAY) for $32.50 Per Share, $4.3 Billion

Feb 12, 2024 08:25 AM

Nov 25, 2019 08:10 AM

Nov 25, 2019 08:02 AM

Nov 25, 2019 08:01 AM

Jan 3, 2017 04:33 PM

Jan 3, 2017 04:06 PM

Jan 3, 2017 04:00 PM

Mar 17, 2016 04:30 PM

Mar 17, 2016 04:01 PM